Maribavir
CAS: 176161-24-3
Ref. TM-T2162
1mg | 42.00 € | ||
2mg | 55.00 € | ||
5mg | 96.00 € | ||
10mg | 138.00 € | ||
25mg | 241.00 € | ||
50mg | 405.00 € | ||
100mg | 597.00 € | ||
1ml*10 (DMSO) | 94.00 € |
Product Information
- BW1263W94, GW257406X, Benzimidavir, 1263W94
- 1263W94
- 1H-Benzimidazol-2-amine, 5,6-dichloro-N-(1-methylethyl)-1-β-<span class="text-smallcaps">L</span>-ribofuranosyl-
- 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl)-1H-Benzimidazole
- 5,6-Dichloro-2-Isopropylamino-1-(-L-Ribofuranosyl)-Lh-Benzimidazole
- 5,6-Dichloro-N-(1-methylethyl)-1-β-<span class="text-smallcaps">L</span>-ribofuranosyl-1H-benzimidazol-2-amine
- 5,6-dichloro-1-[(1S)-pentofuranosyl]-N-(propan-2-yl)-1H-benzimidazol-2-amine
- 5,6-dichloro-N-(1-methylethyl)-1-beta-L-ribofuranosyl-1H-benzimidazol-2-amine
- BENZIMIDAVIR, 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-LH-BENZIMIDAZOLE
- Benzimidavir: 5,6-Dichloro-2-(Isopropylamino)-1-(Ss-L-Ribofuranosyl)-Lh-Benzimidazole
- See more synonyms
- Bw 1263W94
- Gw 257406X
Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.
Chemical properties
Technical inquiry about: TM-T2162 Maribavir
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.